首页> 外国专利> USE OF A DEHYDROEPIANDROSTERONE DERIVATIVE TO ACCELERATE OR INCREASE THE REGENERATION OF THE EPITHELIUM OR THE REGENERATION OF THE ENDOTHELY OF A TISSUE.

USE OF A DEHYDROEPIANDROSTERONE DERIVATIVE TO ACCELERATE OR INCREASE THE REGENERATION OF THE EPITHELIUM OR THE REGENERATION OF THE ENDOTHELY OF A TISSUE.

机译:使用去氢表雄酮衍生物加速或增加上皮的再生或组织内皮的再生。

摘要

THE PRESENT INVENTION REFERS TO THE USE OF A DEHYDROEPIANDROSTERONE (DHEA) DERIVATIVE, AS DESCRIBED HEREIN, OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION THAT ACCELERATES THE RE-EPITELIZATION OR RE-ENDOTELIZATION IN A SUBJECT THAT NEEDS IT. BETWEEN EXAMPLES OF RE-EPITELIZATION FOR WHICH THE INVENTION IS PARTICULARLY ADEQUATE, WITHOUT THE LISTING THAT FOLLOWS LIMITATION, THE RE-EPITELIZATION OF (A) THE SKIN AFTER SURGICAL WOUNDS; (B) CUTANEOUS ABRASIONS CAUSED BY MECHANICAL TRAUMA, CAUSTIC AGENTS OR BURNS; (C) THE CORNEA AFTER THE OPERATION OF CATARATA OR CORNEA TRANSPLANTATION; (D) THE MUCOUS EPITHELIUM (RESPIRATORY, GASTROINTESTINAL, GENITOURINARY, MAMMARY, ORAL, OCULAR, LIVER AND KIDNEY CAVITY) AFTER INFECTION, NON-PATHOLOGICAL ETHOLOGIES OF MEDICINAL THERAPY; (E) SKIN AFTER GRAFT; AND (F) RENAL TUBULES AFTER ACUTE TUBULAR NECROSIS. BETWEEN THE EXAMPLES OF REENDOTHELIZATION FOR WHICH THE INVENTION IS PARTICULARLY APPROPRIATE IS INCLUDED, WITHOUT THE FOLLOWING LISTING MUST BE INTERPRETED BY LIMITATION, THE RE-ENDOTHELIZATION (OR THE RECOVERY OF THE ENDOTHELIS, VASOS DE LAISOS DE LAGOSINE DE LAGOSINE DE LAGUINE DE LAGUINE DE LAGESINE DE LAGUINE SANGUINE DE LAES SANGUINE DE LAES SANGUINE DE LAES SANGUINE OF FIBRINE OR THE LISIS OR MECHANICAL ALTERATION OF THROMBES IN CORONARY ARTERIES. ACCORDING TO THE PRESENT INVENTION, THE TIME NEEDED FOR A COMPLETE REEPITELIZATION OR RE-ENDOTHELIZATION IMPROVES OR IS ACCELERATED BY ADMINISTRATION OF A DEHYDROEPIANDROSTERONE DERIVATIVE (DHEA).
机译:本发明是指使用如本文所述的去氢表雄酮(DHEA)衍生物或该药物的药学可接受的盐来制备可加速重新修饰或重新端接的药物组合物。它。在本发明特别适合的重新认证的例子之间,没有列出以下的限制,重新认证(A)外科手术后皮肤的重新认证; (B)机械性外伤,腐蚀剂或灼伤引起的经常性擦伤; (C)实施卡拉托拉或科妮亚移植后的科妮亚; (D)感染后,药物治疗的非病理学因素后的粘膜上皮(呼吸道,胃肠道,泌尿生殖道,乳腺,口腔,眼,肝和肾腔); (E)移植后的皮肤;和(F)急性肾小管坏死后的肾小管。在包括本发明特别合适的再合成的例子之间,在没有限制的情况下,必须解释以下列举,再内皮化(或内皮托氏菌的回收,DEAS LA DES DE DELAGOS DE LAGOS DE LAGOSINE DE LAGOS DE LAESINE DE LAGOSINE纤维的纤溶或冠状动脉血栓的形成或机械改变,根据本发明,需要时间进行完全的重新授权或重新胶凝,或通过授权进行脱氢表雄酮衍生物(DHEA)。

著录项

  • 公开/公告号ES2174275T3

    专利类型

  • 公开/公告日2002-11-01

    原文格式PDF

  • 申请/专利权人 UNIVERSITY OF UTAH RESEARCH FOUNDATION;

    申请/专利号ES19970936184T

  • 发明设计人 ARANEO BARBARA A.;

    申请日1997-07-31

  • 分类号A61K31/565;A61P17/02;

  • 国家 ES

  • 入库时间 2022-08-22 00:41:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号